SCHEMBL21045980

SCHEMBL21045980

COc1ccccc1CO/N=C(/C)c1c(C)cc(=O)n(O)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
IDH1 O75874 2/20 0.47
GAA P10253 1/20 0.36
MIF P14174 1/20 0.36
LMNA P02545 1/20 0.36
IDO1 P14902 2/20 0.35
TTR P02766 1/20 0.35
CNR2 P34972 2/20 0.35
KCNA5 P22460 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPT P10636 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
GPR55 Q9Y2T6 1/20 0.33
CYP19A1 P11511 1/20 0.33
NQO2 P16083 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045979 1.00 MEN1 (0.49) MEN1KMT2AIDH1GAAMIF
SCHEMBL21045981 1.00 MEN1 (0.49) MEN1KMT2AIDH1GAAMIF
SCHEMBL21045892 0.86 KMT2A (0.50) MEN1KMT2AIDH1GAALMNA
SCHEMBL21045899 0.86 MEN1 (0.61) MEN1KMT2AIDH1GAALMNA
SCHEMBL21045890 0.86 KMT2A (0.50) MEN1KMT2AIDH1GAALMNA
SCHEMBL21045895 0.86 KMT2A (0.50) MEN1KMT2AIDH1GAALMNA
SCHEMBL21045896 0.86 MEN1 (0.61) MEN1KMT2AIDH1GAALMNA
SCHEMBL21045897 0.86 MEN1 (0.61) MEN1KMT2AIDH1GAALMNA
SCHEMBL21045870 0.83 MEN1 (0.54) MEN1KMT2AIDH1LMNASMN1; SMN2
SCHEMBL21045871 0.83 MEN1 (0.54) MEN1KMT2AIDH1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550084-B2 Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same ARBUTUS BIOPHARMA CORPORATION (CA) 2020-02-04 US disclosed
US-20190169128-A1 SUBSTITUTED 1-HYDROXY-PYRIDIN-2(1H)-ONES, AND METHODS OF MAKING AND USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10550084-B2 Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same RNASEH1, RNASE1, RNASEL MEN1 1891/4885KMT2A 1917/4885IDH1 690/4885
US-20190169128-A1 SUBSTITUTED 1-HYDROXY-PYRIDIN-2(1H)-ONES, AND METHODS OF MAKING AND USING SAME RNASEH1, RNASE1, RNASEL MEN1 1891/4885KMT2A 1917/4885IDH1 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.